Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2162-3619
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting ; volume:11 ; number:1 ; day:24 ; month:9 ; year:2022 ; pages:1-17 ; date:12.2022
Experimental hematology & oncology ; 11, Heft 1 (24.9.2022), 1-17, 12.2022
- Creator
-
Wang, Ji-nuo
Gu, Tianning
Hu, Yongxian
Huang, He
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40164-022-00316-8
- URN
-
urn:nbn:de:101:1-2022121221024926683807
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Ji-nuo
- Gu, Tianning
- Hu, Yongxian
- Huang, He
- SpringerLink (Online service)
Other Objects (12)
Special issue: CAR‐T cell therapy for hematological malignancies
The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies
Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia
Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting
Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
An in vivo study of the best light emitting diode (LED) systems for cut chrysanthemums
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair
Outcome of Pneumocystis Jirovecii pneumonia (PcP) in post-CAR-T patients with hematological malignancies
The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation
COVID-19 in Hematologic Malignancies: Big Challenges
How do commodity futures respond to macroeconomic news?
Special issue: CAR‐T cell therapy for hematological malignancies
The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies
Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia
Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting
Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
An in vivo study of the best light emitting diode (LED) systems for cut chrysanthemums
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair
Outcome of Pneumocystis Jirovecii pneumonia (PcP) in post-CAR-T patients with hematological malignancies
The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation
COVID-19 in Hematologic Malignancies: Big Challenges
How do commodity futures respond to macroeconomic news?
Special issue: CAR‐T cell therapy for hematological malignancies
The breakthrough and the future: CD20 chimeric antigen receptor T‐cell therapy for hematologic malignancies
Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia
Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting
Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies
An in vivo study of the best light emitting diode (LED) systems for cut chrysanthemums
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair
Outcome of Pneumocystis Jirovecii pneumonia (PcP) in post-CAR-T patients with hematological malignancies
The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation
COVID-19 in Hematologic Malignancies: Big Challenges